Importantly, we also demonstrate that the ALS8 mutation in dVAP33A interferes with BMP signaling pathways at the neuromuscular junction, identifying a new mechanism underlying pathogenesis of ALS8. The gene discussed is VAPB; the disease is amyotrophic lateral sclerosis type 8.